| CAS NO: | 6882-68-4 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 20mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Sophoridine is a quinolizidine alkaloid isolated from Leguminous plantSophora flavescens. Sophoridine inducesapoptosis. Sophoridine has the potential to be a novel, potent and selective antitumor drug candidate for pancreaticcancerwith well-tolerated toxicity[1]. | ||||||||||||||||||||||||
| 体外研究 (In Vitro) | Sophoridine (0-500 μM; 48 hours) exhibits remarkable inhibition effects to the growth of human pancreatic, gastric, liver, colon, gallbladder, and prostate carcinoma cells with IC50values of about 20 μM to 200 μM[1].Sophoridine (0-20 μM; 48 hours) increases S phase cell population from 26.23% (control) to 38.67% in Miapaca-2 cells and from 29.56% (control) to 39.16% in PANC-1 cells, about a 1.5-fold and a 1.3-fold increase, respectively[1].Sophoridine (0-20 μM; 48 hours) significantly increases bad and bax levels, and decreases bcl-2 and bcl-xl levels in contrast, with a significant increase in Bax/Bcl-2 ratio[1]. Cell Viability Assay[1]
Cell Cycle Analysis[1]
Western Blot Analysis[1]
| ||||||||||||||||||||||||
| 体内研究 (In Vivo) | Sophoridine (intraperitoneal injection; 20 or 40 mg/kg; 21 days) can inhibit the growth of xenograft pancreatic tumors[1].
| ||||||||||||||||||||||||
| 分子量 | 248.36 | ||||||||||||||||||||||||
| 性状 | Solid | ||||||||||||||||||||||||
| Formula | C15H24N2O | ||||||||||||||||||||||||
| CAS 号 | 6882-68-4 | ||||||||||||||||||||||||
| 中文名称 | 槐定碱 | ||||||||||||||||||||||||
| 结构分类 |
| ||||||||||||||||||||||||
| 来源 |
| ||||||||||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
| 储存方式 |
| ||||||||||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 50 mg/mL(201.32 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
